Table 4 Subgroup analyses of the association between the p53 rs1042522 SNP and event-free survival for retinoblastoma invasion.
Genotype | Subgroup | Log-rank analysisa | Cox regression modelb | ||
---|---|---|---|---|---|
Time to RB invasion (median ± SE, months) | P | HR (95% CI) | P | ||
GG/CC | Lag time ≤1 month | 0.5 ± 0.1 | 1.00 (reference) | ||
GC | Lag time ≤1 month | 5.6 ± 2.4 | 0.007 | 0.64 (0.35-1.15) | 0.134 |
GG/CC | Lag time >1 month | 5.0 ± 1.0 | 1.00 (reference) | ||
GC | Lag time >1 month | 8.0 ± 3.5 | 0.008 | 0.31 (0.13-0.73) | 0.007 |
GG/CC | No prior treatment | 0.5 ± 0.2 | 1.00 (reference) | ||
GC | No prior treatment | 3.0 ± 0.8 | 0.004 | 0.50 (0.30, 0.85) | 0.010 |
GG/CC | Pre-enucleation treatment | 13.0 ± 1.0 | 1.00 (reference) | ||
GC | Pre-enucleation treatment | 18.5 ± 6.0 | 0.587 | 0.25 (0.05, 1.14) | 0.072 |